Frimline
Frimline is dedicated to improving chronic disease management through innovative solutions and advanced technology. Collaborating with Enavant Research from the USA, Frimline aims to develop patented products to address the global epidemic of chronic diseases, focusing on early action and prevention to build a healthier tomorrow.
Industries
Nr. of Employees
medium (51-250)
Products
NEURONOMIC PLUS
Oral combination product intended to scavenge free radicals, reduce iron overload, and support cognitive function in patients with neurodegenerative disorders.
PALMIGES FORTE / PALMIGES PLUS
Oral combination formulations designed to address arthritis-related pain and inflammation and to reduce neuronal inflammation; offered in once-daily formats.
PALMIRESP
Anti-inflammatory supplement combining palmitoylethanolamide, Boswellia serrata extract, and pine bark extract intended as an adjuvant for chronic airway inflammation and hyperresponsiveness.
NACYRES PLUS
Combination product containing an N-acetyl derivative (N-acetyl-L-cysteine derivative) and lactoferrin intended to provide synergistic mucolytic action.
IRONEMIC / IRONEMIC PLUS
Oral iron supplementation combinations containing lactoferrin, disodium guanosine 5'-monophosphate, ferrous bisglycinate (elemental iron), and vitamin C (Plus formulation) designed for iron-deficiency anemia and anemia of chronic disease.
FIDOTOX
Oral product containing inulin and betaine formulated to reduce specific protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) in chronic kidney disease and hemodialysis patients via SCFA generation and microbiome modulation.
NEURONOMIC PLUS
Oral combination product intended to scavenge free radicals, reduce iron overload, and support cognitive function in patients with neurodegenerative disorders.
PALMIGES FORTE / PALMIGES PLUS
Oral combination formulations designed to address arthritis-related pain and inflammation and to reduce neuronal inflammation; offered in once-daily formats.
PALMIRESP
Anti-inflammatory supplement combining palmitoylethanolamide, Boswellia serrata extract, and pine bark extract intended as an adjuvant for chronic airway inflammation and hyperresponsiveness.
NACYRES PLUS
Combination product containing an N-acetyl derivative (N-acetyl-L-cysteine derivative) and lactoferrin intended to provide synergistic mucolytic action.
IRONEMIC / IRONEMIC PLUS
Oral iron supplementation combinations containing lactoferrin, disodium guanosine 5'-monophosphate, ferrous bisglycinate (elemental iron), and vitamin C (Plus formulation) designed for iron-deficiency anemia and anemia of chronic disease.
FIDOTOX
Oral product containing inulin and betaine formulated to reduce specific protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) in chronic kidney disease and hemodialysis patients via SCFA generation and microbiome modulation.
Services
Collaborative R&D partnerships
Co-development projects with external research consultancies to develop product solutions for chronic disease management.
Collaborative R&D partnerships
Co-development projects with external research consultancies to develop product solutions for chronic disease management.
Expertise Areas
- Chronic disease management
- Nutraceutical and combination therapy development
- Microbiome-targeted therapies and prebiotic approaches
- Iron-deficiency anemia therapeutics
Key Technologies
- Oral nutraceutical formulation
- Prebiotic-driven microbiome modulation (SCFA generation)
- Lactoferrin-based therapeutics
- Ferrous bisglycinate iron formulations with vitamin C